{
  "content": ". Excluded were patients with more than 3 relapses of persistent atrial fibrillation during the last 3 years, amiodarone use in preceding 3 months, history of relapse of atrial fibrillation under adequate (desethyl)amiodarone levels, New York Heart Association class III or IV heart failure, contraindications for amiodarone, history of thyroid dysfunction, concomitant treatment with class I or III antiarrhythmic drugs, known sick sinus syndrome, second- or third-degree atrioventricular block, or a pacemaker. Patients were seen at the outpatient department at inclusion, after 2 weeks of amiodarone loading, and at 1, 4, 8, 12, 16, 20, and 24 months after randomization",
  "source": "https://jamanetwork.com/journals/jama/fullarticle/182743",
  "chunk_id": "c19d4f86-6a64-40d3-9d9b-37222228be83",
  "similarity_score": 0.3507504463195801,
  "query": "long-term outcomes amiodarone beta-blockers atrial fibrillation follow-up recurrence maintenance therapy",
  "rank": 19,
  "title": "Continuous vs Episodic Prophylactic Treatment With Amiodarone for the Prevention of Atrial Fibrillation: A Randomized Trial",
  "authors": "Sheba Ahmed, MD; Michiel Rienstra, MD, PhD; Harry J. G. M. Crijns, MD, PhD; Thera P. Links, MD, PhD; Ans C. P. Wiesfeld, MD, PhD; Hans L. Hillege, MD, PhD; Hans A. Bosker, MD, PhD; Dirk J. A. Lok, MD; Dirk J. Van Veldhuisen, MD, PhD; Isabelle C. Van Gelder, MD, PhD",
  "year": "2008",
  "journal": "JAMA",
  "reference": "Ahmed, S., Rienstra, M., Crijns, H. J. G. M., Links, T. P., Wiesfeld, A. C. P., Hillege, H. L., Bosker, H. A., Lok, D. J. A., Van Veldhuisen, D. J., & Van Gelder, I. C. (2008). Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: A randomized trial. JAMA, 300(15), 1784â€“1792. https://doi.org/10.1001/jama.300.15.1784",
  "doi": "10.1001/jama.300.15.1784",
  "chunk_index": 26,
  "total_chunks": 106,
  "retrieved_at": "2025-07-24T22:33:54.519284"
}